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Abstract
Using a recently developed mesoscopic theory of protein dielectrics, we have calculated the salt bridge
energies, total residue electrostatic potential energies, and transfer energies into a low dielectric amyloid-
like phase for 12 species and mutants of the prion protein. Salt bridges and self energies play key roles in
stabilizing secondary and tertiary structural elements of the prion protein. The total electrostatic potential
energy of each residue was found to be invariably stabilizing. Residues frequently found to be mutated in
familial prion disease were among those with the largest electrostatic energies. The large barrier to charged
group desolvation imposes regional constraints on involvement of the prion protein in an amyloid aggregate,
resulting in an electrostatic amyloid recruitment profile that favours regions of sequence between alpha helix
1 and beta strand 2, the middles of helices 2 and 3, and the region N-terminal to alpha helix 1. We found
that the stabilization due to salt bridges is minimal among the proteins studied for disease-susceptible human
mutants of prion protein.
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Introduction
Misfolded prion protein is the causative agent for a unique category of human and animal neurodegenerative
diseases characterized by progressive dementia, ataxia, and death within months of onset (Prusiner 1998).
These include Creutzfeldt-Jakob disease (CJD), fatal familial insomnia, and Gerstmann-Stra¨ussler-Scheinker
syndrome in humans, bovine spongiform encephalopathy in cattle, scrapie in sheep, and chronic wasting
disease in cervids. Unlike other infectious conditions that are transmitted by conventional microbes, the
material responsible for propagation of prion diseases consists of an abnormally folded conformer of an
endogenous protein, possibly in complex with host nucleic acids or sulfated glycans (Caughey et al. 2009).
Soluble, natively-folded monomers of the prion protein (known as PrPC) may adopt an aggregated protease-
resistant conformation known as PrPScthat is capable of recruiting additional monomers of PrPCand inducing
them to misfold in a process of template-directed conversion. This results in ordered multimers of prion
protein that, when fractured, act as additional seeds to propagate the misfold through the reservoir of PrPC
present in brain. Although the conversion process may be initiated by an infectious inoculum of PrPSc, it
may also arise spontaneously or due to mutations in the gene coding for PrP that predispose to misfolding.
Structurally, PrPC is a glycophosphatidylinositol-anchored glycoprotein of 232 amino acids comprising
an N-terminal unstructured domain and a C-terminal structured domain of 3 α-helices (hereafter referred
to as α1, α2, and α3 in order) and a short two-stranded antiparallel β-sheet (made of strands β1 and β2),
while PrPSc has substantially enriched β content speculated to form a stacked β-helix (Govaerts et al. 2004)
or extended β-sheet (Cobb et al. 2007) conformation in the amyloid fibril.
At a molecular level PrP misfolding is a physico-chemical process, with the propensity to misfold deter-
mined by the free energy difference between folded and misfolded states and the magnitude of the energy
barrier separating them. As in any protein system, electrostatic effects make significant contributions to the
energies of the various states and take two forms: salt bridge energy due to spatial proximity of charged
groups within the native protein, and solvation/self energy due to field energy storage in the ambient protein
and water dielectric media. A priori, it is expected that electrostatic effects generally favour the well-solvated
monomeric PrPC over the more hydrophobic amyloid PrPSc, since formation of PrPSc necessitates disruption
of salt bridges in the native structure (although this may be compensated for by the formation of alternative
salt bridges in PrPSc) and transfer of some charged groups into an environment of lower permittivity, both of
which are energetically costly. However, these penalties on formation of PrPSc are counterbalanced by hydro-
gen bonding, hydrophobic, and possibly entropic contributions that favour the amyloid form (Tsemekhman
et al. 2007). Regional variation in the electrostatic transfer energy to water and amyloid may be useful in
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predicting participation in the amyloid core of PrPSc. Furthermore, several of the causative mutations for
familial prion disease involve substitution of charged residues for uncharged residues (such as the D178N
mutation responsible for fatal familial insomnia or familial CJD, depending on mutant allele polymorphism
status at codon 129) or charge reversal of a residue (such as E200K, the most common mutation in classical
familial CJD) (Kovacs et al. 2002), offering an indication of the importance of electrostatic effects in the
misfolding process. More broadly, it has been found that changes in the charge state of a mutant protein
compared to wild-type relate to its tendency to form aggregates (Chiti et al. 2003), and the aggregation
propensity of a polypeptide chain is inversely correlated with its net charge (Chiti et al. 2002); similarly, ag-
gregation propensity is maximal at the protein iso-electric point where the net charge is zero (Schmittschmitt
and Scholtz 2003). Intrinsically unstructured proteins tend to have a high net charge (Uversky, Gillespie
and Fink 2000), which increases the electrostatic cost for the system to condense into the folded structure.
Sequence correlations between charged groups may affect the kinetics of amyloid formation as well (Dima
and Thirumalai 2004).
The role of salt bridges in prion disease has been investigated previously by molecular dynamics simulation
(MDS) and experimental studies of mutant protein. MDS of human PrPChas identified salt bridges that play
a role in stabilization of the native structure (Zuegg and Gready 1999). Other MDS studies of the R208H
mutation, which disrupts a salt bridge with residues D144 and E146 of α-helix 1, have shown that it results
in global changes to the backbone structure (Bamdad and Naderi-Manesh 2007). Experimentally, the E200K
mutant of PrPC has been shown through calorimetry to be 4 kJ/mol less stable than wild type (Swietnicki et
al. 1998). Mutation of two aspartates participating in α1 intra-helix salt bridges to neutral residues increases
misfolding fourfold in cell-free conversion reactions under conditions favouring salt bridge formation (Speare
et al. 2003). Interestingly, complete reversal of charges in α1 appears to inhibit conversion, possibly by
preventing docking of PrPC and PrPSc (Speare et al. 2003). The pH dependence of charge interactions in
PrPC has also been investigated to identify those most sensitive to pH changes (Warwicker 1999); this is an
important aspect of the problem because of the observed increased PrPC misfolding rate at low pH.
A unifying analysis of all PrPC salt bridges would be useful in understanding their role in structural
stability. As well, to our knowledge solvation energy contributions to the misfolding process have not yet
been investigated; they would offer a helpful perspective for probing the propensity of different regions of
the prion protein to participate in the PrPSc amyloid core.
Direct extraction of salt bridge and solvation energies from molecular dynamics is complicated by the
need to run long-length simulations that sample the equilibrium between states of interest, which can be
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prohibitively slow for states that differ significantly in energy. An alternative approach is to use a continuum
electrostatics description of the protein-water system, in which the response of surrounding material is
modelled through solution of the Poisson-Boltzmann equation as a macroscopic dielectric that varies from a
low value (usually 4) within the volume of the protein to 78 (the dielectric constant of bulk water) outside
the protein. The downside of this method is that it ignores subtleties of the protein response to perturbing
fields, such as cooperative internal reorganization. Using results from Kirkwood-Fro¨lich theory (Oster and
Kirkwood 1943; Frohlich 1949; Voges and Karshikoff 2000), we have recently developed a procedure to
compute a spatially-varying dielectric function for a protein based on fluctuation statistics obtained from
brief equilibrium MD simulations that capture much of the microscopic response of the protein at moderate
computational cost (Guest et al. 2009). This provides a convenient tool to calculate solvation and salt
bridge energies for all residues in a protein from a single simulation. In what follows we apply this method
to determine the energies for all salt bridges in 12 molecular species of prion protein and the transfer energy
for all residues in these proteins into a hypothetical protein amyloid core.
Methods
Twelve structures of various species and mutants of PrPC were selected from the Protein Data Bank (PDB),
including the species human 1QLZ and 1QLX (Zahn et al. 2000), cow 1DX0 (Lopez Garcia et al. 2000),
turtle 1U5L, frog 1XU0, chicken 1U3M (Calzolai et al. 2005), mouse 1AG2 and 1XYX (Riek et al. 1996;
Gossert et al. 2005), dog 1XYK, pig 1XYQ, cat 1XYJ (Lysek et al. 2005), wallaby 2KFL (Christen et al.
2009) and the human mutants D178N 2K1D (Mills et al. 2009) and E200K 1FKC (Zhang et al. 2000). They
were taken as starting points for 5ns all-atom molecular dynamics simulations using the CHARMM force field
version C31B1 (Brooks et al. 1983) with explicit pure solvent water (no salt), periodic boundary conditions,
particle mesh Ewald electrostatics, a timestep of 2fs, and a Lennard-Jones potential cutoff distance of 13.5A˚.
The basic residues (ARG and LYS) were protonated, while the acidic residues (HIS, ASP, and GLU) were
deprotonated to reflect ionization conditions at pH 7. The system was first minimized for 200 time steps
before starting the simulation. Snapshots of the simulations were taken every 2ps to build up an ensemble of
equilibrium conformations for each protein. The dipole moments µ of all residue side chains and backbones
were calculated at each snapshot and used to obtain the correlation coefficients
Rij =
〈µiµj〉√
〈µ2i 〉
〈
µ2j
〉 (1)
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for all pairs of Cartesian dipole components µi and µj , where the angle brackets denote an average over
all snapshots (the thermal average). The matrix R of correlation coefficients was diagonalized to isolate
the normal modes of dipole fluctuations, which describe the response of charged groups to perturbations
around equilibrium. The R matrix for each protein was used to calculate the local dielectric map (Guest
et al. 2009). See Figure 1 in the Supplementary Material for the dielectric map of human PrP. These
dielectric maps were then taken as input for the Poisson-Boltzmann solver APBS (Baker et al.2001) to solve
the linearized Poisson-Boltzmann equation on an 973 mesh in 150 mM NaCl, again with periodic boundary
conditions, to obtain the electrostatic energies required below. Atomic radii were assigned according to
the CHARMM force field by the program PDB2PQR (Dolinsky et al. 2004). The often-used simplifying
approximation of a constant internal protein dielectric constant of 4 and water dielectric constant of 78 was
employed for comparison (Kumar and Nussinov 1999).
Salt bridges in the set of proteins were identified by searching all pairs of charged atoms for those with
charged groups within 12A˚ of each other, whether the charges were alike or different. The energy of each
salt bridge was determined by a mutation cycle designed to isolate the charge interaction energy from the
energy in the surrounding dielectric milieu as shown in Figure 1. For charged groups A and B, their salt
bridge energy Esb was taken to be a function of the energy of the protein system with both charges in place,
EAB , with one or the other charge removed, EA and EB , and with both charges removed, E0, as follows:
Esb = E0 + EAB − (EA + EB) . (2)
Here, E0 contains only the self energy of the part of the protein not including A and B (labelled P in Figure
1), while EAB contains the self energies of A, B, and P as well as the pairwise interaction energies between
A and B, A and P, and B and P. EA contains the self energies of A and P and their interaction energies (EB
is analogous). Combining the terms as shown causes all the energies except the interaction energy of A and
B to cancel.
Another cycle, also shown in Figure 1, was used to determine the total contribution of each residue to
the electrostatic energy of the protein, Eelec. For each side chain in the protein, the electrostatic energies of
the side chain Esc and the protein lacking the side chain Ewhole−sc were calculated in isolation in the protein
dielectric environment and subtracted from the electrostatic energy of the intact protein Ewhole:
Eelec = Ewhole − Esc − Ewhole−sc. (3)
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The terms Esc and Ewhole−sc contain the self energies of the side chain and rest of the protein respectively,
and Ewhole contains these self energies as well as the interaction energy of the side chain with the rest of
the protein. Subtracting the terms as shown causes the self energies to cancel, leaving only the interaction
energy between the side chain and the protein. This energy can be thought of as the electrostatic potential
energy of a residue in the protein.
To approximate the electrostatic energy of residue transfer into a hydrophobic, low dielectric environment
like the core of a PrPSc amyloid, the energy E(PrPC ) of a residue in the dielectric environment of PrP
C
was compared to the energy E(PrPSc) of the residue in a homogeneous dielectric of  = 4, which describes
the dielectric response in the interior of a bulk amyloid protein phase. Since the nature of monopole fields
in the PrPSc structure is unknown, interactions between charged residues are omitted from the calculation,
so the transfer energy reflects only changes in the dielectric environment. For a given residue, the dielectric
contribution to the transfer energy Etrans is:
Etrans = E(PrPSc)− E(PrPC ). (4)
Results
Dynamics of Dipoles at Equilibrium
The modes obtained by diagonalizing the correlation matrix R in Equation 1 generally involved several parts
of the molecule; correlations were not limited to residues close in space or sequence. This is consistent
with phonon transmission of perturbations at one site throughout the molecule by strong steric coupling
effects through solid-like elastic moduli. The four largest-amplitude dipole modes for human PrP are shown
in Figure 2. Dipole fluctuations were not qualitatively different between species, but different regions of
the molecule exhibited characteristic motions. The two long alpha helices 2 and 3 exhibited primarily
synchronous motion, with the helices rocking back and forth together as a unit. Nonetheless, some dipoles in
the helices exhibited contrary motion. Alpha helix 1 did show some autonomy from the rest of the structure
and tended to fluctuate as a group.
Motion of the beta sheet is prominent in several of the modes. Two patterns stand out: a see-saw motion
in which one strand tilts up as the other tilts down with both strands pivoting about the middle of the
strands, and an in-out motion in which the outer beta strand (β1) and the N-terminal part of α2 move
synchronously away from the inner beta strand (β2). The first motion is seen in modes 2 and 3 in Figure
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2 above, while the second motion is seen in other lesser-amplitude modes. This is compatible with NMR
observations of the beta sheet, which show slow exchange between a range of conformations (Liu et al. 1999;
Viles et al. 2001). In the NMR experiments, motion of the beta strands was observed on a time scale of
microseconds, while these simulations only spanned nanoseconds, but both are indicative of some degree of
conformational flexibility in the beta sheet.
Salt bridge energies
The PrP structures analysed contained a diverse set of salt bridges, ranging from moderately attractive to
weakly repulsive. A complete list of salt bridges in all structures is presented in Table 1 of the Supplementary
Material; salt bridges in the human structure are shown in Table 1 for both the single NMR structure 1QLX
and the ensembe of 20 NMR structures 1QLZ.
Structurally, the salt bridges can be divided into local and nonlocal by the proximity in sequence of the
participating residues. Local salt bridges, like Asp148—Glu152 in α1, Asp208—Glu211 in α3, and Arg164—
Asp167 between β2 and the following loop serve to stabilize secondary structural elements of the protein,
while nonlocal salt bridges like Arg156—Glu196, Arg164—Asp178, and Glu146—Lys204 help to hold these
elements together in the overall tertiary fold. Figure 3 shows the position of these nonlocal salt bridges in
bovine PrP.
Many of the salt bridges identified were near the protein surface, where the high degree of solvation
attenuates their strength; the strongest salt bridges were those best sequestered from solvent, for this places
them in a dielectric environment that increases electric field strength. The strongest salt bridge of all,
between residues 206 and 210 of frog PrP, features a special “two-pronged” geometry that enables the
amino group of Lys 210 to associate with both carboxyl oxygens on Asp 206. Interestingly, two strong but
intermittant salt bridges are present in human 1QLZ between the C-terminal arginine and residue 167 in
the β2− α2 loop and residue 221 in α3. The substantial variation between members of the NMR ensemble
at the C-terminus results in large motion of the arginine side chain, so that these salt bridges are only
formed in a subset of conformers. Similarly, the ARG 164 - ASP 178 salt bridge that helps to anchor the
beta sheet to α2 and α3 is not present in all members of the 1QLZ NMR ensemble, although it is quite
strong in the single 1QLX structure. Although attractive salt bridges predominate, there were a number of
repulsive salt bridges identified as seen on the left hand side of Figure 5A, especially in α1 and α3, which
are crowded with several charged residues. As demonstrated in the following section, despite the presence of
these destabilizing interactions, no residue experiences a net repulsive potential as these unfavourable salt
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bridges are counterbalanced by the presence of other, stronger, favourable ones. The total energies due to
all salt bridges in each molecular species studied are shown in Figure 5B. Of note is the much reduced total
salt bridge energy in the two human mutants, E200K and D178N, compared to any other structure. The
categorization of species as susceptible or resistant to prion disease is somewhat approximate, but comparison
of total salt bridge energy and disease susceptibility by Kendall’s tau gives a value of τ = 0.45, implying
that the order of species by salt bridge energy and disease susceptibility are significantly concordant (p =
0.046). Overall, the effect of a heterogeneous dielectric was to moderate putatively strong salt bridges under
the biphasic protein-water approximation for the dielectric function.
The salt bridges listed in Table 1 of the Supplementary Material are those present at pH 7, but for human
PrP an additional search was performed to identify salt bridges that would emerge at lower pH, since acidic
conditions are known to drive PrPSc formation. Lower pH results in protonation of histidine residues to
produce a positively charged species, which in human PrP enables the formation of three additional weakly
attractive salt bridges (indicated by daggers in Table 1). While the dominant effect of lowering pH is to
reprotonate acidic side chains, thus reducing electrostatic stability, this is partially compensated for by the
formation of salt bridges involving histidine.
Total residue electrostatic energies
The salt bridge energies describe pairwise effects, but for mutational analysis it is more important to know
the total contribution of each side chain to the stability of the protein. These energies approximate the
electrostatic contribution to the energy change on mutation to a residue with a small nonpolar side chain
like alanine. In practice, the side chain of each residue is removed from the protein. The total electrostatic
energy of each residue in all prion proteins studied was less than or equal to 0, indicating a strong degree of
evolutionary selection toward residues that benefit stability in the folded conformation. Through electrically
neutral, or nearly so, proteins have their internal dipoles oriented so as to lower the potential energy of
every residue. In human PrP, it is instructive to correlate the energies to known pathogenic mutations:
the residue with the greatest overall stabilizing energy, Thr183, is implicated in familial CJD by a T183A
mutation (Kovacs et al. 2002); this mutation has also been shown to radically reduce measured stability
by urea denaturation (Liemann and Glockshuber 1999). It is interesting to note that this residue, although
not charged, is polar and more deeply buried in the hydrophobic core of the protein than any other charged
residue, thereby enhancing the effect of dipolar attractions with its neighbors. Other residues that on
mutation cause familial prion disease have especially high total electrostatic stabilizing energies, including
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D178 and D202. Table 3 gives the 10 human side chains with the greatest total electrostatic energies.
We might anticipate that mutation of other residues in Table 3 may enhance the probability of developing
misfolding-related disease.
Transfer to hydrophobic environment
In forming the amyloid core of PrPSc, some residues must undergo the migration to a region of low dielectric
constant. For highly charged residues, this transfer energy is prohibitively high and may thereby exclude
their participation in the amyloid core, while for nonpolar residues the small electrostatic transfer energy cost
is overcome by favourable solvation entropy changes. By mapping the transfer energy of each residue into a
region of low dielectric approximating PrPSc amyloid, it is possible to predict the likelihood of recruitment
for various PrP regions into the amyloid core, without the aid of specific dipole-dipole correlations as might
be present in the amyloid. Figure 6 shows the transfer energy from the PrPC dielectric to a homogeneous
dielectric of 4 for various species of PrPC. The transfer energy to an aqueous environment would show an
inverse pattern. A 7 amino acid summing window is applied because sequence heterogeneity causes large
variation between adjacent residues, and individual residues cannot enter the amyloid core without placing
their neighbors in it as well. The transfer energies in Figure 6 are quite large, but including other terms
in addition to the electrostatic energies considered here will reduce the magnitude of the total transfer free
energy.
There is considerable variation in the transfer energy along the sequence, with the lowest barrier to
dielectric transfer for the region between α1 and β2, the middles of α2 and α3, and β1. Conversely, α1,
the loop between β2 and α2, and the loop between α2 and α3 show a formidable barrier to transfer. This
overall pattern is well preserved among all PrP structures studied (see Supplementary Material Figure
4). Immunological studies have defined β2 as a PrPSc-specific epitope (Paramithiotis et al. 2003), which
presumably necessitates its surface exposure. In the human structure, β2 is located at the border between
regions of low and high transfer energies, so it is possible that it is close in proximity to the amyloid core
but protrudes sufficiently to be recognised by antibodies.
The overall contour of the transfer energy functions is similar for all PrP structures studied, but there
is some variation that correlates with known infectivity data. As seen in Figure 6, human and bovine share
highly similar transfer energy profiles and are both susceptible to prion disease and interspecies transmission
of disease, while non-mammalian turtle PrP that does not form PrPSc has a different profile, with a higher
transfer energy barrier than cow or human over 4/5 of the sequence. PrPC from dog, a mammalian species
10
known to be resistant to prion infection (Polymenidou et al. 2008), is intermediate between the human
and turtle profiles. The average transfer energies correlate with a species’ resistance to disease (Figure 6
legend). Some other species, including chicken, turtle, and wallaby, have a qualitatively different transfer
energy function.
Discussion
Although electrostatic effects are only one contribution to the enigmatic PrPC→ PrPSc conversion process,
they offer clues to many of the central questions in prion biochemistry. The spatial variation of the dielectric
is important, as neither charge separation distance, dielectric constant at the midpoint of the salt bridge,
nor burial can predict salt bridge stability or total electrostatic energy (see Figures 2 and 3 of the Supple-
mentary Material). As shown above, salt bridges play an important role in stabilizing both secondary and
tertiary aspects of the PrPC structure. In fact, the total energy of all salt bridges in human PrPC is -60
kJ/mol, almost twice the total stability of the protein as determined by calorimetry (Swietnicki et al. 1998;
Liemann and Glockshuber 1999). Thus disruption of even a proportion of salt bridges in PrPC is sufficient
to substantially destabilize the folded conformation, possibly accelerating or enabling the transition to PrPSc
in the right conditions. However, as has been observed elsewhere (Hendsch et al. 1996), the free energy
change of salt bridge disruption may not be equal to the Coulombic energy of the salt bridge itself, due to
the competing favourable reduction in desolvation energy. This will partially offset the change in stability
from salt bridge disruption. Charge interactions may also participate in the poorly-understood association
between the unstructured N-terminal domain and structured C-terminal domain of PrPC. As shown previ-
ously, the C-terminal domain organization depends on the length of N-terminal tail present (Li et al. 2009),
possibly through a collection of transient interactions below the detection threshold of NMR, resulting in an
“avidity-enhanced” C-terminal structure. Charge complementarity between the N- and C-terminal domains
provides one explanation for this phenomenon. For example, the very N-terminus of PrPC contains the highly
positively charged region KKRPK from codons 25–29, while α1 contains the highly negatively charged region
DYED from codons 144–147. If the N-terminal tail is free to explore a random walk around the C-terminal
domain, electrostatic attractions are likely to bias this part of the tail toward residence near α1, a region
that is especially influenced by the length of tail present. The net attraction between the N-terminal tail
and C-terminal structure may be insufficient to structure the tail but sufficient to collapse or condense the
tail onto the surface of the structured domain, resulting in a kind of “molten shell.” Further exploration of
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this phenomenon, by molecular dynamics or other tools, may prove insightful.
The importance of acidic conditions in the PrP conversion has been known for some time (Hornemann
and Glockshuber 1998), and acidity exerts a large effect through modification of the protonation states
of charged residues. At slightly acidic pH below the pKa of histidine (6.5), protonation of the histidine
imidazole ring creates mildly stabilizing salt bridges with nearby residues. In the prion literature, histidines
are a subject of considerable attention for their ability to coordinate copper ions in the octapeptide repeat
region of the N-terminal domain (Aronoff-Spencer et al. 2000; Viles et al. 2008), but it seems that they also
help to protect PrPC from the stress of mildly acidic conditions. At much lower pH, however, protonation
of glutamate and aspartate side chains ablates some of the stabilizing salt bridges shown in Table 1, which
substantially reduces the energy barrier to rearrangement of PrPC components. For example, at pH 4.5,
the pKa predictor program PROPKA (Bas et al. 2008) identifies glutamate residues 168, 200, 219, and
221 as being significantly protonated, which will affect the stability of the protein and whose systematic
investigation is a topic for future work. The influence of acidity on the monomeric PrPC structure has been
extensively studied by molecular dynamics (Gu et al. 2003; Langella et al. 2004; DeMarco and Daggett
2007), but perhaps the most noteworthy effect of acidity may not be in the resulting structural transition of
the isolated PrPC monomer but rather in lowering the barrier to induced reorganization in the presence of
the templating species.
Another natural question is the role that electrostatics play in the formation of the PrPSc amyloid. It
may be argued that since the transfer energy profile in Figure 6 neglects the possibility of forming strong
salt bridges in the low dielectric amyloid core of PrPSc it misrepresents the ability of these charges to stably
occupy the amyloid. A counterexample may be constructed in a case of homogeneous dielectrics. The total
energy change ∆Etotal on bringing two opposite charges A and B both of charge q and radius rion from a
large distance apart in a medium with high dielectric solv like water into close proximity rAB in a region
of low dielectric prot to form a salt bridge is equal to the sum of the solvation energy changes ∆E
A
solv and
∆EBsolv and their pairwise Coulomb energy ∆EAB . Treating the charges as Born ions, in the limit where
prot/solv  1 (a valid assumption since generally solv = 78 and prot = 4, so prot/solv ≈ 0.05), the total
energy change to form the desolvated salt bridge is:
∆Etotal = ∆E
A
solv+∆E
B
solv+∆EAB = 2q
2
(
1
2rion
)(
1
prot
− 1
solv
)
− q
2
protrAB
≈ q
2
prot
(
1
rion
− 1
rAB
)
. (5)
This is always positive since rAB is greater than rion to satisfy the stereochemistry of the atoms. Thus
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although salt bridges may partially mitigate the burial of charged residues, they cannot alter the fundamental
unfavourability of the electrostatic component of this process. It is also possible that solvent-exposed salt
bridges may form in the misfolded state outside or on the surface of the amyloid or oligomeric core, which
could occur without the desolvation penalty described above. This would provide a mechanism to stabilize
charged and polar parts of the protein in the misfolded form. Such salt bridges are likely to be relatively
low in energy due to the high ambient dielectric environment, and it has been observed for amyloid-beta
16-22 peptide that hydrophobic forces are more important than specific salt bridges in driving amyloid
formation (Ma and Nussinov 2002). However as mentioned above, it has been shown that the net charge of
a polypeptide chain incurs resistance to aggregation (Chiti et al. 2002; Schmittschmitt and Scholtz 2003),
consistent with the notion of a higher overall energetic cost of transfer into a low dielectric medium for more
highly charged polypeptides. In light of this, we believe the transfer energy profiles accurately convey this
part of the obstacle to amyloid formation.
Continuum electrostatics as a tool to examine protein behaviour has limitations, namely that it ignores
the microscopic response of the system and thereby risks omitting subtle but important effects. However, by
deriving the dielectric map from all-atom molecular dynamics simulations of the proteins of interest, we are
able to substantially incorporate the microscopic response in our model and thereby improve the reliability
of the energy estimates obtained. Previous theories could not reliably predict the effective dielectric constant
inside a protein, so values typically between 4 and 10 have been used as initial guesses. Stronger salt bridges
in the interior tend to be better predicted by an interior dielectric of 4, which would then overestimate the
strength of the more abundant salt bridges on the protein surface. An interior dielectric of 10 best predicts the
strength of the abundant surface salt bridges, but would then underestimate the strength of the buried interior
salt bridges. The heterogeneous dielectric theory in (Guest et al. 2009) makes it unnecessary to guess at the
value of the dielectric inside a protein and also indicates that no single value in the interior is satisfactory.
Quantum effects due to electronic polarizability may be added to this approach as further refinement. The
conformational variability in the ensemble of NMR structures for each PrP molecule also introduces an
inherent uncertainty in the calculation of electrostatic energies, which we treated by averaging salt bridge
energies over all NMR ensemble members. The molecular dynamics relaxation methods, often done in
the absence of counterions, may introduce uncertainty as well. Electrostatic considerations are relevant to
many aspects of the prion question, from PrPC dynamics and stability to PrPSc amyloid organization and
templating. We have presented an analysis of salt bridge, electrostatic, and hydrophobic transfer energies
that provides a useful perspective for understanding the structural vulnerabilities of PrPC.
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Figure 1: Schematic of the approach for calculating salt bridge and total electrostatic energies. Circular
arrows denote solvation/self energies; straight arrows denote interaction energies. Labels refer to quantities
in Equations 2 and 3.
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Figure 2: The 4 largest amplitude dipole correlation modes for human PrP. Regions of the same colour move
in synchrony, while regions of different colours move in opposition.
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Figure 3: Stereo view of the three well-conserved nonlocal salt bridges as they are arranged in bovine PrP.
The transparent surfaces show contours of equal dielectric (5 for blue; 70 for white) as determined from
heterogeneous mesoscopic dielectric theory (Guest et al. 2009).The volume near the surface of the protein
shows the greatest difference in dielectric on comparison of the homogeneous and heterogeneous dielectric
fields. See also Figure 1 in the supplementary material for a surface plot of the dielectric permittivity as a
function of position.
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Cat 147 - 151 (-11.6) Chicken 159 - 215 (+5.2)Cat 156 - 202 (-11.8)Wallaby 156 - 202 (-13.3)Frog 206 - 210 (-29.7)
Figure 4: The 4 most attractive salt bridges (in black lettering) and the 1 most repulsive (in red lettering)
identified in the set of PrP structures. Numbers in parentheses are the salt bridge energies in kJ/mol for the
structures indicated. Note that interactions with all surrounding residues were considered when assessing
the total effect of each residue on overall stability, as given in Table 3 and Supplementary Table 2.
1QLX 1QLZ 1QLX 1QLZ
Residues Involved r Esb(1) Esb(1)
δEsb(1)
Esb(1)
Esb(2) Esb(2)
δEsb(2)
Esb(2)
(A˚) (kJ/mol) (kJ/mol) (kJ/mol) (kJ/mol)
†HIS 140 ASP 147 6.6 -4.0 -3.7 0.30 -4.6 -4.2 0.40
ASP 144 ASP 147 7.6 2.7 4.4 0.19 2.9 5.4 0.32
GLU 146 LYS 204 7.4 -2.5 -3.0 0.29 -2.5 -3.4 0.43
ARG 148 ARG 151 7.9 1.8 2.2 1.23 1.4 2.3 0.51
ARG 148 GLU 152 4.8 -7.4 -5.0 0.25 -35.4 -14.6 0.51
ARG 156 GLU 196 4.9 -5.5 -5.1 0.32 -18.2 -11.8 0.96
ARG 156 ASP 202 7.1 -3.8 -3.0 0.27 -4.8 -3.8 0.39
ARG 164 ASP 167 6.9 -3.0 -2.4 0.54 -3.7 -2.7 0.95
ARG 164 ASP 178 6.0 -20.4 -4.8 1.23 -48.2 -8.2 1.44
†HIS 177 GLU 207 6.6 -2.8 -2.8 0.43 -2.7 -3.1 0.58
†HIS 187 ASP 202 8.0 -3.0 -3.2 0.25 -5.1 -4.6 0.30
GLU 196 ASP 202 7.9 2.9 2.4 0.22 2.9 2.7 0.25
GLU 200 LYS 204 4.1 -4.9 -3.7 0.39 -7.5 -6.5 0.85
ARG 208 GLU 211 2.6 -9.3 -5.8 0.30 -37.9 -14.9 0.66
Table 1: Salt bridges in the human prion protein from 1QLX (a single structure) and 1QLZ (an ensemble of
20 structures). †: Only present at low pH. The separation between charged groups is given by r. Esb(1) is
the salt bridge energy (an average for 1QLZ) calculated with the heterogeneous dielectric theory, and Esb(2)
is the same energy calculated with a constant protein dielectric of 4. The standard deviation of salt bridge
energy over the structures in the NMR ensemble containing the salt bridge is given as a fraction of the total
salt bridge energy by δEsbEsb . The correlation coefficient between salt bridge energies from 1QLX and 1QLZ is
0.82.
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Figure 5: A. Histogram of average energies for all salt bridges identified. B. Total salt bridge energies in the
molecular species studied. Error bars give the 95% confidence interval for the mean salt bridge energy from
each ensemble of NMR structures.
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Figure 6: Hydrophobic transfer energy for strands of 7 residues centred on a given residue index as calculated
from Equation 4 for 4 species of PrPC. The numbers in the upper left hand corner give the average transfer
energy over the whole protein. Shown below are the locations of secondary structural elements in the PrPC
sequence.
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PDB Species Residues Involved n Esb(1)
δEsb(1)
Esb(1)
Esb(2)
δEsb(2)
Esb(2)
(/20) (kJ/mol) (kJ/mol)
1XU0 Frog ASP 206 LYS 210 20 -21.4 0.31 -42.2 0.37
1QLZ Human WT GLU 221 ARG 228 12 -13.7 0.07 -76.6 0.07
2KFL Wallaby ARG 156 ASP 202 20 -13.3 0.88 -18.0 0.90
1QLZ Human WT ASP 167 ARG 228 11 -13.1 0.06 -75.5 0.08
1XYJ Cat ARG 156 ASP 202 20 -11.8 0.45 -21.5 0.69
1XYJ Cat ASP 147 ARG 151 20 -11.6 0.27 -40.9 0.33
2KFL Wallaby ARG 156 GLU 196 20 -10.9 0.32 -29.6 0.51
1XYX Mouse ARG 156 ASP 202 20 -10.4 0.37 -18.9 0.46
1QLZ Human WT ASP 147 ARG 151 20 -9.9 0.38 -30.4 0.53
1XYX Mouse GLU 146 LYS 204 20 -9.7 0.26 -27.2 0.44
...
...
...
...
...
...
...
...
...
...
...
2K1D Human D178N ARG 156 LYS 194 20 3.4 0.42 4.9 0.84
1XYQ Pig GLU 207 GLU 211 20 3.4 0.24 4.0 0.30
1FKC Human E200K LYS 204 ARG 208 20 3.4 0.15 3.7 0.24
1XYQ Pig ARG 148 ARG 151 20 3.5 0.09 4.1 0.24
1XYX Mouse GLU 207 GLU 211 10 3.5 0.14 4.0 0.20
1XYK Dog GLU 207 GLU 211 20 4.0 0.18 4.8 0.25
1QLZ Human WT ASP 144 ASP 147 19 4.4 0.18 5.4 0.31
1XU0 Frog LYS 197 LYS 210 19 4.7 0.49 7.7 0.84
2KFL Wallaby GLU 196 ASP 202 20 4.9 0.14 7.4 0.22
1U3M Chicken GLU 159 GLU 215 20 5.2 0.15 6.2 0.43
Table 2: The most attractive and repulsive salt bridges in the set of prion protein structures studied. The
number of NMR conformers for each species in which the salt bridge is present is n. Esb(1) is the salt bridge
energy (an average for 1QLZ) calculated with the heterogeneous dielectric theory, and Esb(2) is the same
energy calculated with a constant protein dielectric of 4. The standard deviation of salt bridge energy over
the structures in the NMR ensemble containing the salt bridge is given as a fraction of the total salt bridge
energy by δEsbEsb .
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Res Site Eelec (kJ/mol) Eelec/ Avg(Eelec)
1QLX
THR 183 α2 -197 6.0
ASP 147 α1 -196 5.9
TYR 150 α1 -171 5.2
ARG 136 β1-α1 -151 4.6
ASP 202 α3 -137 4.2
ARG 164 β2 -99 3.0
ASP 178 α2 -96 2.9
GLU 221 α3 -92 2.8
TYR 157 α1-β2 -75 2.3
VAL 210 α3 -73 2.2
1QLZ
THR 183 α2 -171 5.9
TYR 150 α1 -171 5.9
ASP 202 α3 -135 4.6
TYR 157 α1-β2 -97 3.3
ARG 164 β2 -81 2.8
THR 192 α2-α2 -67 2.3
ASP 178 α2 -67 2.3
VAL 210 α3 -65 2.2
ARG 136 β1-α1 -63 2.1
GLU 221 α2 -61 2.1
Table 3: Residues in human PrP (1QLX and 1QLZ) with the greatest total electrostatic energy from Equation
4. The last column gives the factor by which each residue’s electrostatic energy exceeds the average for all
residues in the protein (-33 kJ/mol). THR 183 has the lowest electrostatic energy in human PrP and is also
a minimum on the hydrophobic transfer profile (see Figure 6), due presumably to its low dielectric local
environment. VAL 210 appears in the list despite being a putatively nonpolar residue because it is located
in a region of particularly low dielectric in the protein core, which increases the energy of its small side chain
methyl group dipoles. β1-α1: Between α1 and β1. α1-β2: Between α1 and β2. Bold: Wild-type residues
at the locations of known mutation sites in familial prion diseases. The correlation between transfer energies
from 1QLX and 1QLZ is 0.87. With 90% confidence, the list is significantly enriched in pathologic mutations
compared to random chance (p = 0.096).
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Figure 1: Local heterogeneous dielectric map of human PrP as calculated by mesoscopic dielectric theory (Guest et al.,
2009). This is a slice taken through the geometric centre of the molecule in the X-Y plane.
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Table 1: Salt bridges in 13 structures of the prion protein with a
repulsive or attractive energy greater than 3 kJ/mol. The number
of NMR conformers in which the participating charged groups are
within a distance of 12A˚ is n. Esb(1) is the salt bridge energy cal-
culated according to Equation 2 with the heterogeneous dielectric
theory, and Esb(2) is the same energy calculated with a constant
protein dielectric of 4. The standard deviation of salt bridge en-
ergy over the structures in the NMR ensemble containing the salt
bridge is given by δEsb and as a fraction of the total salt bridge
energy by δEsbEsb .
PDB Species Residues n Esb(1) δEsb(1)
δEsb(1)
Esb(1)
Esb(2) δEsb(2)
δEsb(2)
Esb(2)
Involved (/20) (kJ/mol) (kJ/mol) (kJ/mol) (kJ/mol)
1DX0 Bovine 147 151 20 -6.4 3.5 0.54 -15.2 12.6 0.83
1DX0 Bovine 164 178 20 -3.1 1.9 0.60 -6.2 6.3 1.02
1DX0 Bovine 156 196 20 -6.0 2.8 0.47 -12.1 8.7 0.72
1DX0 Bovine 156 202 20 -7.8 5.5 0.71 -13.0 10.7 0.82
1DX0 Bovine 200 204 20 -3.1 1.4 0.46 -4.1 5.9 1.44
1DX0 Bovine 208 211 20 -5.1 1.9 0.38 -10.4 10.2 0.98
1FKC Human E200K 164 167 19 -3.0 1.1 0.38 -3.2 2.0 0.64
1FKC Human E200K 164 178 20 -4.6 1.0 0.23 -7.0 3.8 0.55
1FKC Human E200K 156 196 20 -3.1 0.7 0.22 -3.2 1.5 0.46
1FKC Human E200K 156 202 20 -3.2 0.7 0.21 -4.6 1.5 0.34
1FKC Human E200K 146 204 20 -5.2 1.6 0.31 -8.6 5.1 0.59
1FKC Human E200K 204 208 20 3.4 0.5 0.15 3.7 0.9 0.25
1FKC Human E200K 208 211 20 -4.2 0.6 0.14 -5.2 1.8 0.33
1QLZ Human WT 144 147 19 4.4 0.8 0.19 5.4 1.7 0.32
1QLZ Human WT 144 151 16 -3.5 1.0 0.29 -4.1 2.5 0.60
1QLZ Human WT 147 151 20 -9.9 3.8 0.39 -30.4 16.2 0.53
1QLZ Human WT 148 152 19 -5.0 1.2 0.25 -14.6 7.5 0.51
1QLZ Human WT 164 168 12 -3.3 1.7 0.53 -4.9 6.5 1.32
1QLZ Human WT 164 178 15 -4.8 5.9 1.23 -8.2 11.8 1.44
1QLZ Human WT 156 196 20 -5.1 1.6 0.32 -11.8 11.4 0.96
1QLZ Human WT 146 204 18 -3.0 0.9 0.29 -3.4 1.4 0.43
1QLZ Human WT 200 204 20 -3.7 1.5 0.39 -6.5 5.5 0.85
1QLZ Human WT 204 207 15 -3.1 1.4 0.45 -3.7 5.9 1.58
1QLZ Human WT 208 211 20 -5.8 1.8 0.30 -14.9 9.9 0.66
1QLZ Human WT 167 228 11 -13.1 0.9 0.07 -75.5 5.7 0.07
1QLZ Human WT 221 228 12 -13.7 1.0 0.07 -76.6 5.7 0.07
1U3M Chicken 150 153 20 -5.0 1.3 0.25 -10.1 7.3 0.72
1U3M Chicken 155 159 20 -3.8 0.7 0.19 -5.2 2.3 0.43
1U3M Chicken 171 185 20 -5.4 1.6 0.29 -12.4 6.7 0.54
1U3M Chicken 159 215 20 5.2 0.8 0.15 6.2 2.7 0.44
1U3M Chicken 163 219 20 -8.4 4.3 0.51 -20.6 15.9 0.77
1U3M Chicken 217 221 20 -5.7 1.1 0.20 -15.3 7.6 0.50
1U3M Chicken 225 229 20 -4.1 1.8 0.44 -5.9 7.7 1.30
1U3M Chicken 139 237 20 -4.1 2.0 0.48 -6.0 6.0 0.99
1U5L Turtle 143 146 20 -3.3 0.7 0.21 -5.8 2.3 0.40
1U5L Turtle 165 169 18 -3.0 2.2 0.74 -5.0 7.1 1.42
1U5L Turtle 164 179 20 -5.1 2.8 0.55 -7.9 7.9 1.00
1U5L Turtle 175 179 20 -4.2 2.8 0.68 -6.9 7.3 1.06
Continued. . .
2
PDB Species Residues n Esb(1) δEsb(1)
δEsb(1)
Esb(1)
Esb(2) δEsb(2)
δEsb(2)
Esb(2)
Involved (/20) (kJ/mol) (kJ/mol) (kJ/mol) (kJ/mol)
1U5L Turtle 156 202 16 -3.1 2.5 0.79 -4.2 6.8 1.63
1U5L Turtle 146 204 20 -5.7 1.8 0.32 -15.1 10.8 0.71
1U5L Turtle 191 207 20 -4.6 2.6 0.56 -7.5 8.7 1.15
1XU0 Frog 148 152 20 -3.3 1.3 0.39 -4.7 6.2 1.31
1XU0 Frog 169 176 19 -3.1 1.6 0.52 -5.6 6.6 1.17
1XU0 Frog 175 179 20 -3.1 1.3 0.43 -4.8 7.0 1.45
1XU0 Frog 169 180 19 3.0 1.4 0.46 4.1 2.8 0.69
1XU0 Frog 188 192 20 -9.4 1.8 0.19 -19.3 6.3 0.33
1XU0 Frog 197 206 20 -5.3 3.4 0.63 -10.2 11.9 1.16
1XU0 Frog 197 210 19 4.7 2.3 0.50 7.7 6.5 0.85
1XU0 Frog 206 210 20 -21.4 6.7 0.32 -42.2 15.9 0.38
1XU0 Frog 163 221 20 -9.4 6.1 0.64 -16.9 13.6 0.80
1XU0 Frog 221 224 20 -5.0 3.6 0.72 -11.5 12.1 1.05
1XYJ Cat 147 151 20 -11.6 3.1 0.27 -40.9 13.4 0.33
1XYJ Cat 164 178 20 -4.7 2.5 0.54 -11.7 11.9 1.01
1XYJ Cat 156 202 20 -11.8 5.3 0.44 -21.5 15.0 0.70
1XYJ Cat 146 204 20 -3.9 2.0 0.51 -5.7 8.7 1.51
1XYJ Cat 200 204 20 -3.5 0.9 0.26 -4.0 3.4 0.85
1XYJ Cat 208 211 20 -5.8 3.0 0.52 -11.8 11.3 0.96
1XYK Dog 144 147 20 3.1 1.0 0.32 3.9 2.0 0.52
1XYK Dog 144 148 20 -4.1 2.1 0.51 -9.3 9.1 0.97
1XYK Dog 147 151 20 -8.4 4.5 0.54 -22.5 16.5 0.73
1XYK Dog 148 152 20 -3.1 1.2 0.39 -5.3 5.8 1.09
1XYK Dog 164 178 20 -3.6 2.2 0.60 -7.4 9.3 1.25
1XYK Dog 136 202 2 -4.0 0.8 0.19 -6.1 0.8 0.12
1XYK Dog 200 204 20 -3.1 1.2 0.40 -3.8 4.7 1.22
1XYK Dog 204 207 20 -3.8 1.4 0.38 -5.6 6.2 1.11
1XYK Dog 207 211 20 4.0 0.7 0.16 4.8 1.2 0.26
1XYK Dog 208 211 20 -5.3 2.5 0.48 -11.5 11.3 0.98
1XYQ Pig 147 151 20 -4.3 1.3 0.29 -6.0 4.1 0.69
1XYQ Pig 148 151 20 3.5 0.3 0.09 4.1 1.0 0.24
1XYQ Pig 164 178 20 -5.9 1.5 0.25 -11.9 7.0 0.59
1XYQ Pig 200 204 20 -4.0 1.3 0.33 -7.0 6.4 0.91
1XYQ Pig 204 207 20 -3.3 1.2 0.37 -3.0 2.1 0.71
1XYQ Pig 207 211 20 3.4 0.8 0.23 4.0 1.2 0.30
1XYQ Pig 208 211 20 -5.9 2.5 0.42 -9.8 12.1 1.24
1XYQ Pig 220 223 19 -3.8 1.2 0.33 -3.6 2.4 0.67
1XYX Mouse 144 147 12 3.2 0.8 0.25 3.2 1.3 0.41
1XYX Mouse 147 151 16 -5.1 2.0 0.38 -9.2 7.9 0.85
1XYX Mouse 148 152 12 -3.8 1.7 0.44 -7.8 9.3 1.18
1XYX Mouse 164 178 18 -5.4 2.4 0.45 -10.8 11.0 1.02
1XYX Mouse 156 196 13 -3.7 1.0 0.28 -4.2 2.5 0.61
1XYX Mouse 194 196 16 -3.5 0.7 0.21 -3.0 0.7 0.23
1XYX Mouse 156 202 20 -10.4 3.9 0.37 -18.9 8.8 0.46
1XYX Mouse 146 204 20 -9.7 2.5 0.26 -27.2 11.9 0.44
1XYX Mouse 146 208 10 -3.2 0.3 0.10 -3.8 0.9 0.23
1XYX Mouse 204 208 18 3.2 0.4 0.13 3.6 0.9 0.24
1XYX Mouse 207 211 10 3.5 0.5 0.15 4.0 0.8 0.20
Continued. . .
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PDB Species Residues n Esb(1) δEsb(1)
δEsb(1)
Esb(1)
Esb(2) δEsb(2)
δEsb(2)
Esb(2)
Involved (/20) (kJ/mol) (kJ/mol) (kJ/mol) (kJ/mol)
1XYX Mouse 208 211 10 -4.4 1.1 0.24 -6.2 5.8 0.94
1XYX Mouse 167 221 2 4.5 0.1 0.03 5.7 0.8 0.14
1XYX Mouse 227 230 10 -3.7 1.9 0.51 -6.9 7.9 1.15
2K1D Human D178N 144 147 20 3.3 0.4 0.13 3.6 0.9 0.23
2K1D Human D178N 147 151 20 -3.7 1.1 0.30 -5.1 3.2 0.63
2K1D Human D178N 164 185 19 3.3 1.5 0.45 3.7 2.8 0.78
2K1D Human D178N 156 194 20 3.4 1.4 0.40 4.9 4.1 0.85
2K1D Human D178N 156 202 16 -3.5 1.9 0.53 -5.5 5.1 0.93
2K1D Human D178N 208 211 19 -3.6 1.2 0.32 -3.0 1.4 0.46
2KFL Wallaby 147 151 20 -5.4 2.7 0.51 -14.6 11.3 0.77
2KFL Wallaby 148 152 20 -3.6 1.4 0.40 -7.9 7.6 0.96
2KFL Wallaby 164 178 20 -4.8 1.9 0.39 -8.3 7.8 0.93
2KFL Wallaby 178 185 19 -3.3 0.9 0.27 -3.7 1.6 0.42
2KFL Wallaby 156 196 20 -10.9 3.5 0.32 -29.6 15.1 0.51
2KFL Wallaby 156 202 20 -13.3 11.7 0.88 -18.0 16.2 0.90
2KFL Wallaby 196 202 20 4.9 0.7 0.13 7.4 1.6 0.22
2KFL Wallaby 200 204 20 -4.6 1.1 0.24 -7.4 5.5 0.74
2KFL Wallaby 204 207 20 -4.2 0.7 0.17 -4.4 1.2 0.28
2KFL Wallaby 146 208 20 -3.7 0.3 0.09 -4.6 0.9 0.20
2KFL Wallaby 208 211 20 -3.8 0.9 0.25 -4.8 5.0 1.04
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Figure 2: A. Absolute salt bridge energies as a function of the reciprocal of the separation distance between the participating
charged groups. B. Absolute salt bridge energies as a function of the reciprocal of the separation distance multiplied by
the dielectric constant  at the midpoint of the line joining the charged groups. In a homogeneous dielectric environment,
the energy of a salt bridge connecting charges qA and qB would be given by Esb =
1
4pi0
qAqB
 r . Including 1/ in the fit in
addition to 1/r improves the correlation from 0.63 to 0.76, but even taken together the quantities  and r do not reliably
predict salt bridge energies. Thus a direct calculation of energies from the full heterogeneous dielectric map is necessary
to obtain accurate results.
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Table 2: Total electrostatic energies in kJ/mol for every residue in a
selection of 13 prion protein structures at pH 7. The energies are
calculated according to Equation 3.
Res 2KFL 1QLX 1FKC 2K1D 1DX0 1U3M 1U5L 1XU0 1XYJ 1XYK 1XYQ 1XYX 1AG2
Wallaby Human Human Human Bovine Chicken Turtle Frog Cat Dog Pig Mouse Mouse
WT E200K D178N
120 S -11 S -7
121 V -9 V -2
122 V -2 V -4 V -4 V -2 V -4 V -3
123 G -1 G 0 G -1 G -1 G -1 G -1
124 G -1 G 0 G -1 G -1 G -1 G -1
125 L -19 L -7 L -7 L -15 L -5 L -8 L -23 L -6
126 G -1 G -1 G -1 G -1 G -1 G 0 G -2 G -1 G -1 G -1 G -1 G -1
127 G -1 G -1 G -1 G -2 G 0 S -7 G 0 G -2 G 0 G -1 G 0 G -1 G -1
128 Y -42 Y -32 Y -28 Y -18 Y -52 V -2 Y -23 Y -18 Y -21 Y -18 Y -27 Y -28 Y -27
129 M -11 M -9 M -8 V -6 M -7 V -2 A -2 M -8 M -7 M -5 M -4 M -9 M -8
130 L -15 L -10 L -10 L -4 L -12 G -1 L -9 L -11 L -14 L -7 L -7 L -5 L -14
131 G -2 G -5 G -5 G -1 G -2 G 0 G -2 G -3 G -2 G -1 G 0 G -3 G -4
132 S -21 S -18 S -16 S -7 S -11 L -3 S -11 N -34 S -9 S -14 S -8 S -12 S -13
133 A -1 A -3 A -1 A -1 A -1 G 0 A -2 A -2 A -1 A -1 A -1 A -3 A -3
134 M -8 M -6 M -24 M -9 M -30 G 0 M -10 V -19 M -11 M -6 M -8 M -8 M -22
135 S -8 S -8 S -14 S -9 S -15 Y -10 S -16 G -1 S -38 S -19 S -10 S -9 S -11
136 R -382 R -151 R -140 R -55 R -63 A -3 G -1 R -55 R -44 R -46 R -56 R -22 R -119
137 P -8 P -10 P -15 P -4 P -7 M -7 M -16 M -22 P -15 P -6 P -12 P -15 P -8
138 V -6 I -11 I -10 I -5 L -7 G -3 R -35 S -15 L -4 L -22 L -5 M -3 M -4
139 M -15 I -20 I -18 I -37 I -43 R -59 M -7 Y -16 I -18 I -9 I -20 I -16 I -26
140 H -23 H -25 H -27 H -20 H -20 V -13 N -14 Q -13 H -12 H -15 H -25 H -16 H -15
141 F -29 F -18 F -47 F -24 F -32 M -13 F -23 F -24 F -23 F -20 F -27 F -27 F -19
142 G 1 G 1 G -1 G 0 G 0 S -16 D -26 N -15 G 0 G 0 G 0 G 0 G 0
143 N -17 S -9 S -19 S -10 S -26 G -1 R -32 N -27 N -33 N -14 S -10 N -12 N -15
144 E -46 D -36 D -39 D -40 D -36 M -10 P -4 P -3 D -37 D -40 D -37 D -37 D -45
145 Y -13 Y -11 Y -12 Y -10 Y -11 N -11 E -29 M -6 Y -12 Y -19 Y -10 W -19 W -18
146 E -40 E -39 E -80 E -43 E -78 Y -40 E -90 E -127 E -54 E -70 E -43 E -51 E -45
147 D -75 D -196 D -70 D -61 D -91 H -14 R -76 S -31 D -57 D -53 D -92 D -54 D -86
148 R -54 R -34 R -48 R -59 R -34 F -12 Q -26 R -50 R -36 R -25 R -48 R -40 R -70
149 Y -52 Y -20 Y -42 Y -23 Y -27 D -32 W -57 Y -77 Y -25 Y -31 Y -19 Y -52 Y -106
150 Y -86 Y -171 Y -132 Y -68 Y -143 R -42 W -81 Y -58 Y -49 Y -58 Y -79 Y -52 Y -114
151 R -97 R -43 R -55 R -43 R -69 P -2 N -47 N -57 R -51 R -37 R -61 R -36 R -46
152 E -39 E -31 E -39 E -57 E -31 D -33 E -45 D -73 E -37 E -42 E -67 E -50 E -78
153 N -53 N -25 N -49 N -31 N -30 E -33 N -36 Y -23 N -28 N -85 N -41 N -74 N -158
154 Q -25 M -24 M -16 M -4 M -8 Y -17 S -10 Y -16 M -8 M -5 M -13 M -10 M -13
155 Y -17 H -19 H -27 H -19 H -18 R -41 N -15 N -13 Y -13 Y -9 Y -13 Y -13 Y -21
156 R -128 R -29 R -41 R -60 R -97 W -36 R -77 Q -14 R -53 R -68 R -57 R -133 R -242
157 Y -145 Y -75 Y -148 Y -18 Y -140 W -52 Y -9 M -41 Y -109 Y -66 Y -52 Y -128 Y -228
158 P -16 P -12 P -9 P -6 P -37 S -13 P -3 P -32 P -9 P -4 P -5 P -10 P -12
159 N -21 N -32 N -52 N -14 N -38 E -54 N -59 N -17 N -17 D -54 N -16 N -17 N -22
160 Q -23 Q -34 Q -18 Q -24 Q -16 N -56 Q -27 R -80 Q -26 Q -23 Q -34 Q -26 Q -24
161 V -63 V -53 V -64 V -26 V -54 S -20 V -34 V -61 V -50 V -27 V -43 V -51 V -49
162 M -19 Y -25 Y -25 Y -34 Y -32 A -1 Y -29 Y -38 Y -32 Y -34 Y -21 Y -40 Y -50
163 Y -59 Y -51 Y -40 Y -31 Y -39 R -30 Y -42 R -83 Y -45 Y -26 Y -23 Y -36 Y -30
164 R -59 R -99 R -63 R -62 R -74 Y -15 K -30 P -28 R -52 R -82 R -84 R -56 R -182
165 P -16 P -5 P -5 P -8 P -5 P -5 E -47 M -7 P -3 P -3 P -3 P -5 P -4
166 I -25 M -19 M -21 M -2 V -13 N -48 Y -152 Y -33 V -15 V -7 V -24 V -16 V -34
167 D -34 D -41 D -58 D -48 D -31 R -67 N -12 R -35 D -35 D -38 D -54 D -32 D -39
168 Q -20 E -31 E -39 E -70 Q -11 V -47 D -34 G -1 Q -18 Q -16 Q -17 Q -15 Q -20
169 Y -137 Y -16 Y -8 Y -7 Y -8 Y -31 R -48 E -93 Y -7 Y -6 Y -15 Y -40 Y -10
170 G -1 S -25 S -27 S -9 S -18 Y -52 S -10 E -41 S -28 S -25 S -8 S -13 S -10
171 S -12 N -20 N -17 N -13 N -19 R -36 V -22 Y -10 N -15 N -28 N -18 N -13 N -13
172 Q -22 Q -11 Q -21 Q -15 Q -30 D -29 P -3 V -17 Q -15 Q -15 Q -24 Q -12 Q -70
173 N -15 N -11 N -16 N -13 N -18 Y -131 E -36 S -14 N -10 N -13 N -17 N -13 N -17
174 S -14 N -12 N -14 N -17 N -15 S -7 G -1 E -49 N -11 N -11 S -11 N -13 N -34
Continued. . .
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Res 2KFL 1QLX 1FKC 2K1D 1DX0 1U3M 1U5L 1XU0 1XYJ 1XYK 1XYQ 1XYX 1AG2
Wallaby Human Human Human Bovine Chicken Turtle Frog Cat Dog Pig Mouse Mouse
WT E200K D178N
175 F -79 F -53 F -54 F -28 F -45 S -12 R -134 D -36 F -30 F -18 F -73 F -24 F -79
176 V -18 V -9 V -19 V -19 V -14 P -3 F -68 R -47 V -6 V -14 V -46 V -10 V -10
177 H -17 H -17 H -16 H -16 H -18 V -4 V -9 F -56 H -14 R -29 H -15 H -11 H -17
178 D -69 D -96 D -63 N -32 D -56 P -3 R -39 V -10 D -42 D -52 D -39 D -41 D -78
179 C -14 C -15 C -12 C -11 C -13 Q -24 D -127 R -46 C -6 C -8 C -11 C -9 C -16
180 V -22 V -11 V -12 V -18 V -9 D -31 C -13 D -60 V -16 V -15 V -38 V -9 V -6
181 N -19 N -14 N -18 N -17 N -14 V -3 V -21 C -11 N -13 N -20 N -24 N -9 N -19
182 I -30 I -29 I -14 I -31 I -18 F -60 N -19 Y -13 I -26 I -9 I -26 I -10 I -31
183 T -212 T -197 T -172 T -158 T -193 V -20 I -36 N -18 T -166 T -157 T -165 T -174 T -219
184 V -14 I -34 I -37 I -22 V -14 A -1 T -178 M -15 V -41 V -8 V -48 I -12 I -10
185 K -21 K -19 K -23 K -29 K -23 D -37 V -31 S -133 R -50 K -16 K -21 K -18 K -18
186 Q -51 Q -23 Q -26 Q -20 E -88 C -13 T -19 V -9 Q -20 Q -58 Q -24 Q -28 Q -33
187 H -29 H -37 H -43 H -34 H -41 F -22 E -59 T -26 H -26 H -76 H -19 H -50 H -39
188 T -29 T -22 T -34 T -56 T -34 N -15 Y -20 E -84 T -66 T -11 T -56 T -18 T -24
189 T -21 V -4 V -6 V -4 V -4 I -14 K -13 Y -107 V -7 V -3 V -8 V -3 V -4
190 T -16 T -18 T -11 T -12 T -26 T -133 I -29 I -13 T -18 T -17 T -26 T -15 T -28
191 T -19 T -23 T -19 T -73 T -99 V -20 D -149 I -8 T -22 T -31 T -51 T -54 T -26
192 T -49 T -51 T -50 T -33 T -16 T -18 P -4 K -21 T -27 T -8 T -20 T -19 T -26
193 T -11 T -17 T -21 T -8 T -16 E -43 N -15 P -4 T -13 T -8 T -13 T -10 T -15
194 K -16 K -19 K -15 K -16 K -20 Y -43 E -50 A -2 K -14 K -25 K -19 K -18 K -16
195 G 0 G 0 G 0 G 0 G 0 S -8 N -36 E -29 G 0 G 0 G 0 G 0 G -1
196 E -53 E -30 E -41 E -37 E -48 I -14 Q -13 G 0 E -83 E -67 E -46 E -40 E -78
197 N -22 N -12 N -18 N -18 N -13 G -1 N -13 K -19 N -11 N -13 N -11 N -19 N -18
198 F -34 F -10 F -34 F -11 F -42 P -2 V -19 N -17 F -24 F -21 F -16 F -35 F -23
199 T -37 T -29 T -55 T -32 T -16 A -2 T -14 N -22 T -17 T -34 T -16 T -30 T -63
200 E -35 E -37 K -17 E -33 E -30 A -1 Q -17 S -8 E -31 E -31 E -33 E -36 E -33
201 T -34 T -20 T -25 T -20 T -14 K -9 V -6 E -27 T -14 T -25 T -13 T -23 T -25
202 D -304 D -137 D -290 D -122 D -235 K -14 E -104 L -14 D -123 D -340 D -86 D -161 D -372
203 I -9 V -5 V -5 V -8 I -7 N -14 V -18 N -16 M -8 M -5 V -7 V -6 V -7
204 K -12 K -9 K -12 K -8 K -7 T -12 R -46 Q -15 K -15 K -11 K -13 K -12 K -11
205 I -58 M -20 M -40 M -13 M -42 S -10 V -74 L -14 I -39 I -70 M -15 M -40 M -18
206 M -49 M -37 M -46 M -17 M -39 E -27 M -28 D -119 M -24 M -34 I -42 M -47 M -32
207 E -61 E -44 E -36 E -60 E -42 A -2 K -23 T -14 E -51 E -36 E -69 E -39 E -45
208 R -35 R -35 R -32 R -73 R -41 V -4 Q -16 T -13 R -58 R -30 R -45 R -32 R -27
209 V -86 V -66 V -58 V -30 V -56 A -1 V -60 V -51 V -50 V -41 V -84 V -47 V -63
210 V -80 V -73 V -73 V -55 V -75 A -3 I -81 K -95 V -67 V -61 V -82 V -66 V -86
211 E -52 E -41 E -42 E -59 E -44 A -2 Q -16 S -11 E -53 E -47 E -94 E -37 E -56
212 Q -24 Q -17 Q -21 Q -104 Q -20 N -18 E -46 Q -19 Q -33 Q -23 Q -25 Q -14 Q -23
213 M -31 M -27 M -38 M -30 M -41 Q -13 M -31 I -82 M -36 M -26 M -35 M -36 M -38
214 C -14 C -12 C -16 C -13 C -14 T -12 C -12 I -54 C -8 C -12 C -11 C -7 C -19
215 I -7 I -7 I -17 I -28 I -10 E -44 M -5 R -40 V -10 V -7 I -24 V -5 V -33
216 T -17 T -24 T -57 T -51 T -20 V -9 Q -29 E -50 T -23 T -24 T -30 T -28 T -50
217 Q -66 Q -53 Q -82 Q -21 Q -54 E -25 Q -36 M -52 Q -43 Q -53 Q -60 Q -45 Q -46
218 Y -34 Y -23 Y -51 Y -91 Y -22 M -3 Y -22 C -14 Y -40 Y -37 Y -48 Y -22 Y -122
219 Q -17 E -37 E -44 E -26 Q -15 E -55 Q -28 I -10 Q -19 Q -17 Q -27 Q -15 Q -32
220 N -25 R -53 R -77 R -33 R -56 N -13 Q -18 T -23 K -16 K -15 K -16 K -20 K -16
221 E -220 E -92 E -77 E -88 E -91 K -9 Y -33 E -196 E -42 E -43 E -58 E -53 E -43
222 Y -18 S -19 S -40 S -14 S -11 V -29 Q -56 Y -64 S -52 S -25 Y -16 S -29 S -43
223 Q -22 Q -15 Q -17 Q -13 Q -17 V -19 L -8 R -41 E -39 E -43 E -79 Q -13 Q -16
224 A -2 A -2 A -2 A -2 A -3 T -24 A -2 R -63 A -2 A -1 A -2 A -2 A -2
225 A -2 Y -16 Y -26 Y -17 Y -21 K -15 G 0 Y -11 Y -11 Y -11 Y -11 Y -15
226 Q -21 Y -9 Y -22 Y -9 Y -13 V -16 Y -35 Y -11 A -1 Y -11
227 R -46 Q -14 Q -24 Q -14 I -56 Q -18 Q -22 Q -13 D -29
228 Y -9 R -41 R -30 R -47 R -28 R -33 R -37 G 0
229 Y -11 G 0 G 0 E -47 R -29 G 1 G -1 R -39
230 S -8 S -9 M -41 A -1 A -1 A -1 R -26
231 C -9 S -8
232 V -12
233 Q -22
234 Q -67
235 Y -41
Continued. . .
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Res 2KFL 1QLX 1FKC 2K1D 1DX0 1U3M 1U5L 1XU0 1XYJ 1XYK 1XYQ 1XYX 1AG2
Wallaby Human Human Human Bovine Chicken Turtle Frog Cat Dog Pig Mouse Mouse
WT E200K D178N
236 R -35
237 E -55
238 Y -22
239 R -36
240 L -3
241 A -1
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Figure 3: Total electrostatic energies of side chains in human PrP calculated from Equation 3 plotted as a function
of solvent-accessible surface area (SASA), a statistic related to burial in the core of the protein. There is a weak but
significant (p = 0.01) correlation between the energy and SASA, but SASA alone is a poor proxy for the electrostatic
energy.
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Figure 4: Hydrophobic transfer energies from Equation 4 for seven residue contiguous segments of 12 prion protein
structures. The residue index gives the position of the middle residue in each segment.
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